OncoTherapy Science (4564) · RiskWorsened
Pharmaceutical Adverse-Effect and Product Liability Risks
First written in FY2016. 1 of 3 entries say "Restated". Latest entry: FY2018.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Health Damage and Product Liability Risks Associated with PharmaceuticalsA theme 58 companies write about · 67 as a headwind · 1 as a tailwind
OncoTherapy Science moved to the "Worse" side of this theme in 2018, 7 years before the typical company in this theme (2025).
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
1 other company's latest entry also says "Worsened".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.Full recordFilings, disclosures and news, newest first
- FY2018WorsenedAnnual report
「In addition, the cancer precision medicine-related businesses, including immunotherapy, in which the group is involved may also experience unexpected adverse reactions.」
The scope of the adverse-reaction risk was explicitly expanded from conventional pharmaceuticals to include immunotherapy related to cancer precision medicine. - FY2017RestatedAnnual report
「Unexpected adverse reactions may occur from the clinical trial stage through the period after product launch.」
The company continues to state that adverse reactions and product liability may affect business performance, its business, and confidence in its pharmaceuticals. - FY2016First statedAnnual report
「Unexpected adverse reactions may occur from the clinical trial stage through the period after product launch.」
The company identifies as risks the direct impact of adverse reactions on business performance and their impact on confidence in and the image of its pharmaceuticals.